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Evolution is a natural event that enables the animal and plant kingdoms to adapt and survive to changing environmental effects. The same evolutionary pressures also help to shape microorganisms including viruses. The evolutionary significance of virus infections has been a subject of discussion for decades; 2 however, modern genomic analysis became an important focus of research when it became apparent that genetic variants of viruses could be linked to pathogenesis and disease progression. 7, 8 However, studies of viral diversity and its association with viral evolution are infrequent and attempts to explain mechanisms leading to HBeAgseroconversion remain speculative.
In their paper published in GUT, Cheng and colleagues shed new light on the relationship between virus diversity, cumulative evolutionary changes and HBeAg-seroconversion in CHB (see page XX). 1 They carefully explored the long term progression of HBV quasi-species relative to the time point of HBeAg-seroconversion. By performing a follow-up study (up to ten years) using preserved serum samples of CHB-patients, the viral diversity of HBeAgseroconverters was compared with non-seroconverters. In order to determine the initiation of viral evolution during CHB the authors estimated HBV-diversity by using pairwise distances under a general time reversible (GTR) model of nucleotide evolution. They observed a gradual increase of viral diversity in seroconverters that started seven years before HBeAgseroconversion occurred. Increases in viral diversity were accompanied by a generally higher evolutionary rate in seroconverters resulting in more distantly related virus species as illustrated in their phylogenetic analysis.
Cheng and colleagues then addressed the question of whether there is a preferred localization of sequence variations in the HBV-genome during viral evolution. Remarkably, study. 10 Here, Cheng and colleagues demonstrated that respective aa-substitutions can occur years before HBeAg-seroconversion.
The appearance of these aa-substitutions during the immune clearance phase was also described in 1996; however, a correlation with HBeAg-seroconversion was not noted.
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Subsequently, cell culture experiments using recombinant HBV-genomes bearing single mutations at either position P5 or L60 revealed an extracellular phenotype with significantly reduced virion secretion but normal intracellular viral replication. 12 Despite a potential disadvantage for the virus, like diminished secretion, it could be assumed that sufficient pressure may drive the virus to evolve towards the selection of aa-changes within specific sites. Since these arising mutations remain stably integrated after HBeAg-seroconversion the hypothesis of immune escape mutations seems to be well supported.
Cheng and colleagues have analysed 2,600 sequences in order to substantiate their hypothesis. Although cumulative viral evolutionary changes appear to precede HBeAgseroconversion, next generation sequencing (NGS) will bring additional and substantial indepth information. NGS may help to identify molecular processes leading to the onset of specific genetic changes in coding and core promoter regions during the natural course of CHB and during antiviral treatment.
How does the study of Cheng and colleagues help us to understand the role of HBV diversity, the emergence of precore/core variants in the scope of cumulative viral evolution during HBeAg-seroconversion and thus affecting antiviral treatment success and outcome of liver disease? First, the authors demonstrated that the increase in HBV quasi-species is linked to mutations occurring predominantly in the HBV precore/core region. They hypothesized that specific immune pressure on T-cell epitopes may alter tolerance of CD4/CD8 T-cell reactivity whereas increased viral diversity can be responsible for stimulating the innate immune system. Of significance the selection of a greater number of sites in T-cell epitopes has recently been described supporting their role in host immunity. 8 Secondly, mutations in the precore/core region can influence HBV capsid stability which in turn can affect virus maturation, virus secretion and viral load. Accordingly, complex immune-(alteration of immune response) and virus-mediated processes (replication fitness) can interact in harmony in shaping HBV evolution. The findings provided by Cheng et al. add new insights to our knowledge of the complex processes of viral evolution, viral diversity, and selection of HBV quasi-species in chronic hepatitis B. We are still at the beginning of understanding these processes of viral evolution and the association with pathogenesis in general and in particular with CHB and HBeAgseroconversion. However, from the perspective of the HBV, viral evolution generating well adapted viral quasi-species is a perfect strategy to assimilate to changing environments including host barriers, host immune response, and antiviral therapy.
